In May 2024, the American Society of Clinical Oncology (ASCO) published new guidelines for germline genetic testing in patients with cancer (1). Introduction to hereditary cancer and germline ..
Genetics as we know and understand it today has been shaped, over decades, by the work of many dedicated scientists around the world, and they all deserve our praise and recognition. To illust..
A comprehensive single-cell transcriptomic atlas of 1.3 million cells from aged human brains reveals cellular pathways linked to Alzheimer’s disease. This study uncovers region-specific neuron vuln..
Infertility is a struggle for many individuals nowadays. According to the World Health Organization (WHO), 1 in 6 people experience infertility, showing the increasing need for the use of alternative..
A recent study highlights promising outcomes for BRCA variant carriers with breast cancer undergoing breast-conserving therapy. Analyzing 172 women, the research found that despite higher risks of ip..
Epidermolysis bullosa (EB), sometimes called butterfly skin, is a group of rare skin diseases with a common symptom: fragile skin that tears and blisters easily. Children with this disease are someti..
In the rapidly evolving field of human genetics diagnostics, laboratories face the challenge of keeping up with the latest advancements in technology while ensuring efficient operations and high-qual..
A timeline of key discoveries in genetics: from Darwin to The Human Genome Project
Genetics as we know and understand it today has been shaped, over decades, by the work of many dedicated scientists around the world, and they all deserve our praise and recognition. To illust..
All about genetics
Hereditary breast and ovarian cancer
Cancer can sometimes run in families; in fact, it is estimated that 5-10% of all cancer cases are inherited. This includes up to 10% of breast cancers and up to 25% of ovarian cancers. The characteri..
Hereditary diseases
Movember is all about men’s health
The month of November, also known as Movember, has been chosen as the month to raise awareness about men’s health. During Movember, men are encouraged to grow a moustache, or participate in an even..
Health and well-being
A timeline of key discoveries in genetics: from Darwin to The Human Genome Project
Genetics as we know and understand it today has been shaped, over decades, by the work of many dedicated scientists around the world, and they all deserve our praise and recognition. To illust..
All about genetics
Hereditary breast and ovarian cancer
Cancer can sometimes run in families; in fact, it is estimated that 5-10% of all cancer cases are inherited. This includes up to 10% of breast cancers and up to 25% of ovarian cancers. The characteri..
Hereditary diseases
Movember is all about men’s health
The month of November, also known as Movember, has been chosen as the month to raise awareness about men’s health. During Movember, men are encouraged to grow a moustache, or participate in an even..
Health and well-being
Our editors are a diverse group of scientists and physicians specialized in different areas of genetics and genetic testing technologies. Owing to our various backgrounds, our editors represent a broad range of expertise and are responsible for the content shared on our website. Only evidence-based, peer-reviewed, and up-to-date content is shared, and all text is continuously edited to maximize its correctness.
Medicover Genetics’ technology transfer platform offers comprehensive testing in a single sequencing run, making it a unique and efficient solution for laboratories of any size. With our Technology Transfer platform, laboratories can perform multi-disciplinary genetic tests such as NIPT, cardiac, hereditary cancer, carrier screening, and metabolic testing all in a single sequencing run. This improves turnaround time and reduces operational costs while ensuring high-quality results with no compromise on accuracy. Our comprehensive testing approach is ideal for laboratories looking to provide a wide range of genetic tests to their healthcare associates and patients.
Our Technology Transfer platform workflow is designed to minimize the risk of errors, reduce hands-on processing and increase the accuracy of test results, providing confidence to patients and physicians in making informed decisions with our user-friendly protocols. The implementation of these protocols ensures that laboratory personnel are trained to follow standardized procedures, reducing the likelihood of human error, and increasing the quality of results.
Medicover Genetics’ versatile Technology Transfer platform can be integrated in a single workflow, offering a multidisciplinary portfolio of genetic tests. VERACITY, VERACITY High Content (HC) and TarCET IVD kits are CE-marked and include user friendly color identification formatting. VERACITY and VERACITY HC kits contain 96 reactions and TarCET IVD kits contain 16 reactions.
We work closely with laboratories to meet their unique needs and goals. We understand that every laboratory is different, and we tailor our approach to accommodate the specific requirements of each partner. In collaboration with our partners, we design a seamless integrated process, from initial setup to ongoing support and maintenance. Our experienced team provides technical, commercial, and marketing assistance to ensure a successful partnership and optimal performance. We aim to build long-lasting partnerships that are mutually beneficial.
